Government cannot mandate HIV drug coverage, rules Texas judge
U.S. District Judge Reed O'Connor has ruled that the Affordable Care Act's mandate for free coverage of HIV prevention drugs violates the religious freedom of a Christian-owned company, Bloomberg reports.
Braidwood Management Inc. had challenged the provision requiring it to cover Truvada and Descovy, a pair of widely-used pre-exposure prophylactic drugs more commonly known as PrEP. Thousands of Americans — especially gay and bisexual men — take PrEP daily as a preventative measure against HIV.
In their initial complaint, the plaintiffs argued that the ACA mandate "forces religious employers to provide coverage for drugs that facilitate and encourage homosexual behavior, prostitution, sexual promiscuity, and intravenous drug use." O'Connor ultimately sided with the plaintiffs, claiming the defendants did not show a "compelling interest in forcing private, religious corporations to cover PrEP drugs with no cost-sharing and no religious exemptions."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The suit was led by attorney Jonathan Mitchell, the former Republican solicitor general of Texas who is known for his efforts to restrict abortion access in the state. Mitchell argues that the entire preventive services mandate under the ACA is invalid because those who manage the list are too empowered to not have Senate confirmation, Bloomberg writes.
At this time, it's unclear whether O'Connor's ruling will be nationally endorsed; still, it could have a major impact on access to preventative care and important free health services for Americans. "It's a disappointing decision because it has broader implications for harm for folks that are just trying to work and live and access health care," attorney Shelley Skeen told NBC News.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Nigel Farage: was he a teenage racist?Talking Point Farage’s denials have been ‘slippery’, but should claims from Reform leader’s schooldays be on the news agenda?
-
Pushing for peace: is Trump appeasing Moscow?In Depth European leaders succeeded in bringing themselves in from the cold and softening Moscow’s terms, but Kyiv still faces an unenviable choice
-
Sudoku medium: November 29, 2025The daily medium sudoku puzzle from The Week
-
Nitazene is quietly increasing opioid deathsThe explainer The drug is usually consumed accidentally
-
More adults are dying before the age of 65Under the radar The phenomenon is more pronounced in Black and low-income populations
-
Ultra-processed AmericaFeature Highly processed foods make up most of our diet. Is that so bad?
-
Climate change is getting under our skinUnder the radar Skin conditions are worsening because of warming temperatures
-
Is this the end of ultraprocessed foods?Today's Big Question California law and the MAHA movement are on the same track
-
Bluetoothing: the phenomenon driving HIV spike in FijiUnder the Radar ‘Blood-swapping’ between drug users fuelling growing health crisis on Pacific island
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
